Observational Secondary Data Study Describing Treatment With Dapagliflozin Among Adult Chronic Kidney Disease Patients
NCT06203704
·
clinicaltrials.gov ↗
COMPLETED
Status
1086
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Kidney Disease (CKD)
Sponsor
AstraZeneca